NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.

by Alexandra Hebar, Barbara C Rütgen, Edgar Selzer
Published 2012-01-01

Flow Cytometric Assessment of Ki-67 Expression in Lymphocytes From Physiologic Lymph Nodes, Lymphoma Cell Populations and Remnant Normal Cell Populations From Lymphomatous Lymph No...

by Barbara C. Rütgen, Daniel Baumgartner, Andrea Fuchs-Baumgartinger, Antonella Rigillo, Ondřej Škor, Sabine E. Hammer, Armin Saalmüller, Ilse Schwendenwein
Published 2021-06-01

Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.

by James W Wells, Christopher H Evans, Milcah C Scott, Barbara C Rütgen, Timothy D O'Brien, Jaime F Modiano, Goran Cvetkovic, Slobodan Tepic
Published 2013-01-01

Breed-associated risks for developing canine lymphoma differ among countries: an European canine lymphoma network study

by Stefano Comazzi, Stefano Marelli, Marzia Cozzi, Rita Rizzi, Riccardo Finotello, Joaquim Henriques, Josep Pastor, Frederique Ponce, Carla Rohrer-Bley, Barbara C. Rütgen, Erik Teske
Published 2018-08-01

Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.

by Barbara C Rütgen, Saskia Willenbrock, Nicola Reimann-Berg, Ingrid Walter, Andrea Fuchs-Baumgartinger, Siegfried Wagner, Boris Kovacic, Sabine E Essler, Ilse Schwendenwein, Ingo Nolte, Armin Saalmüller, Hugo Murua Escobar
Published 2012-01-01